cGMP Signals Modulate cAMP Levels in a Compartment-Specific Manner to Regulate Catecholamine-Dependent Signaling in Cardiac Myocytes - Wikidata - wikimedia - TriplyDB

cGMP Signals Modulate cAMP Levels in a Compartment-Specific Manner to Regulate Catecholamine-Dependent Signaling in Cardiac Myocytes

cGMP Signals Modulate cAMP Levels in a Compartment-Specific Manner to Regulate Catecholamine-Dependent Signaling in Cardiac Myocytes

http://www.wikidata.org/entity/Q29306674

about

The inotropic effect of the active metabolite of levosimendan, OR-1896, is mediated through inhibition of PDE3 in rat ventricular myocardium Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease Phosphodiesterase Inhibition and Regulation of Dopaminergic Frontal and Striatal Functioning: Clinical Implications Imaging alterations of cardiomyocyte cAMP microdomains in disease Molecular regulation of NKCC2 in the thick ascending limb Phosphodiesterases maintain signaling fidelity via compartmentalization of cyclic nucleotides Spatial control of cAMP signalling in health and disease Inhibition of type 5 phosphodiesterase counteracts β2-adrenergic signalling in beating cardiomyocytes Cross-regulation of Phosphodiesterase 1 and Phosphodiesterase 2 Activities Controls Dopamine-mediated Striatal α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Trafficking PDE2A2 regulates mitochondria morphology and apoptotic cell death via local modulation of cAMP/PKA signalling Attenuated response of L-type calcium current to nitric oxide in atrial fibrillation.FRET biosensor uncovers cAMP nano-domains at β-adrenergic targets that dictate precise tuning of cardiac contractility.Advances in targeting cyclic nucleotide phosphodiesterases Role of phosphodiesterase 2 in growth and invasion of human malignant melanoma cells Cyclic nucleotide phosphodiesterases: important signaling modulators and therapeutic targets.Soluble guanylate cyclase is required for systemic vasodilation but not positive inotropy induced by nitroxyl in the mouse.sGC{alpha}1 mediates the negative inotropic effects of NO in cardiac myocytes independent of changes in calcium handling Agents increasing cyclic GMP amplify 5-HT4-elicited positive inotropic response in failing rat cardiac ventricle.Plasma membrane calcium pump (PMCA4)-neuronal nitric-oxide synthase complex regulates cardiac contractility through modulation of a compartmentalized cyclic nucleotide microdomain.Cardiac role of cyclic-GMP hydrolyzing phosphodiesterase type 5: from experimental models to clinical trials.Pathological cardiac hypertrophy alters intracellular targeting of phosphodiesterase type 5 from nitric oxide synthase-3 to natriuretic peptide signaling.PKA and PDE4D3 anchoring to AKAP9 provides distinct regulation of cAMP signals at the centrosome.Roles of phosphodiesterases in the regulation of the cardiac cyclic nucleotide cross-talk signaling network SERCA Cys674 sulphonylation and inhibition of L-type Ca2+ influx contribute to cardiac dysfunction in endotoxemic mice, independent of cGMP synthesis.The NO/cGMP pathway inhibits transient cAMP signals through the activation of PDE2 in striatal neurons.Interactions of Calcium Fluctuations during Cardiomyocyte Contraction with Real-Time cAMP Dynamics Detected by FRET.Clinical and molecular genetics of the phosphodiesterases (PDEs).Phosphodiesterases and subcellular compartmentalized cAMP signaling in the cardiovascular system.Phosphodiesterases and cyclic GMP regulation in heart muscle.Compartmentation of cAMP signalling in cardiomyocytes in health and disease.Biophysical techniques for detection of cAMP and cGMP in living cells.Novel approaches and opportunities for cardioprotective signaling through 3',5'-cyclic guanosine monophosphate manipulation.The cGMP/PKG pathway as a common mediator of cardioprotection: translatability and mechanism.β-adrenergic receptor signalling and its functional consequences in the diseased heart.Mechanisms of the cyclic nucleotide cross-talk signaling network in cardiac L-type calcium channel regulation.Dysregulation of Neuronal Ca2+ Channel Linked to Heightened Sympathetic Phenotype in Prohypertensive States Identification of a novel microRNA important for melanogenesis in alpaca (Vicugna pacos).Phosphodiesterases 3 and 4 Differentially Regulate the Funny Current, If, in Mouse Sinoatrial Node Myocytes Non-genomic effects of spironolactone and eplerenone in cardiomyocytes of neonatal Wistar rats: do they evoke cardioprotective pathways?Differential regulation of cardiac excitation-contraction coupling by cAMP phosphodiesterase subtypes.

P2860

Q21131829-6DF629D0-5974-4440-8614-6F1589537BAC Q24323316-D234BA70-0DBE-4817-B9C0-D099031FB717 Q26753116-5DCD5868-BB1A-4476-A24E-22F2B09AE4F1 Q26785322-A06AEC6B-326F-44C0-BB47-75315C093B30 Q26853028-1A014CB5-A074-4D87-8039-B428F0644AFF Q26860508-35820DAF-5A4E-4445-A843-1959728465DA Q26866056-F69F3FE9-2C72-47BF-AE8C-43606CD596E1 Q27967859-D0707ECB-9B48-4C66-AF6E-12098BF6F400 Q28392899-657EE11F-3EF0-436F-9CD5-CC8E46645631 Q33112068-98B4FB2C-72D9-423B-8F1B-102CB8238196 Q33585378-841A4D3A-473E-4EE9-99AE-190C5A4D7269 Q33622017-DE8EB7D2-E8BD-428C-A70E-9F1E75164331 Q34139490-1D2E711E-3899-4206-8B73-DF27061B4235 Q34241272-30606768-3E73-468C-B50A-753BC56834A7 Q34765802-83F6D161-DB7F-4F26-AFBF-8F7601FF3011 Q34892722-FA3FDEAB-F2A1-40B2-9AD5-5CF48D903325 Q35087054-A0931D5E-52E6-4366-A405-864495FEF63A Q35563508-ED99CD58-ADD5-4415-AE26-17ABA5922709 Q35842187-B5D9603A-A257-4025-825F-FB4D6940873B Q36128551-51563408-B5A1-40DE-9005-87B9685EF655 Q36191580-9DA1A998-D3CC-4E9E-A79D-8C73D6BA84D4 Q36444266-8831D7E4-D997-4B46-9A1E-3B73C014D2A1 Q36609843-95760676-D401-442B-B807-E8AB6EC9444E Q37234941-240A1857-6585-4147-980F-564D16B78862 Q37317832-4658E6D3-16EB-42CB-A95E-07C8EBC7F73D Q37486049-F37BF683-5DA8-4EE4-B76D-660E38455282 Q37657841-5D4CC816-2778-4C75-B85F-E7977C6C0E16 Q37950792-254CAE81-0309-451D-AB6B-AF18A2153970 Q38033089-A4C57275-9D87-4AB9-9606-764E170B9FB2 Q38079253-0ADB692A-AFA5-4649-8723-49EF3EF914BD Q38098831-880DF193-30A1-471F-9091-014E9367A344 Q38191314-8645BD90-BAA4-421F-A993-E8868C5C393A Q38258238-2D04CC96-F1AA-4A75-805F-DE2ECE04ABFB Q38722030-9645F48F-EA26-48A5-8AFD-C66A2D3263FE Q38862807-24A465D6-1320-4072-8587-4E01FF148E28 Q39479507-6221F06B-9FC6-4B84-A091-7CA31818FE5D Q40894310-5BC25876-C762-4BB4-AFAC-C768691EBDEE Q41533475-07603921-63D5-4C07-8CFD-C0714CDBF01B Q41714003-1094EF5E-17C8-4587-8EC8-8DEB51333CA4 Q41865256-0846257A-2037-4846-AE1C-EDF6AEB953AF

P2860

cGMP Signals Modulate cAMP Levels in a Compartment-Specific Manner to Regulate Catecholamine-Dependent Signaling in Cardiac Myocytes

http://www.wikidata.org/entity/Q29306674

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

cGMP Signals Modulate cAMP Lev ...... Signaling in Cardiac Myocytes

@ast

cGMP Signals Modulate cAMP Lev ...... Signaling in Cardiac Myocytes

@en

type

label

cGMP Signals Modulate cAMP Lev ...... Signaling in Cardiac Myocytes

@ast

cGMP Signals Modulate cAMP Lev ...... Signaling in Cardiac Myocytes

@en

prefLabel

cGMP Signals Modulate cAMP Lev ...... Signaling in Cardiac Myocytes

@ast

cGMP Signals Modulate cAMP Lev ...... Signaling in Cardiac Myocytes

@en

P1433

Q29306674-54967831-A94D-4A93-BEC5-B5FFA530E9D5

P1476

Q29306674-48F49127-4FBD-4507-9CF1-533F9FDE3727

P2093

Q29306674-12993AC9-8CDD-401B-8132-89D3D9B23B25

Q29306674-241B5224-9692-4A83-B80C-8B83AAD47C4D

Q29306674-31F78ACB-EC46-4302-833D-0B2F446051D2

Q29306674-390B8FFE-93BF-4161-8D23-9C4E3F20EB0E

Q29306674-4B833D61-8DAA-460B-8431-C5C25A6E01F1

Q29306674-64FEDAD3-E5A8-4BC2-8574-D99C36C78F7A

Q29306674-7042D1C1-6580-44BB-A4FC-0BE3F3F2DC04

Q29306674-DF4F20E9-6CE3-4DA6-90BB-106195A5A6C5

P2860

Q29306674-06DEE402-46D3-4D9D-962D-FE1390BA4298

Q29306674-0F13E1CD-F6CC-446F-9937-CB1C5400B69E

Q29306674-252B5810-751E-439E-A297-BA4E500B5B4C

Q29306674-28E78E33-F7EF-4848-9D92-63AECDC863C7

Q29306674-3AF3584B-AE4E-46F4-AAC9-E9FBFC11B91F

Q29306674-3E953D06-2531-41DA-B1B9-CF9FE1EF3BD9

Q29306674-3F0B5CAB-2FD9-4BEF-B06A-5682D148ADC1

Q29306674-45FAC72E-048B-418F-B7D7-812A267D58B4

Q29306674-4DD12D1A-D137-47FD-B554-225EAE8D846B

Q29306674-4ED4A662-13EE-478F-8C35-0D832395CC90

P304

Q29306674-87BAAD57-E459-4648-BE04-E38F3307241A

P31

Q29306674-437C9EC3-0484-48C9-B646-C82702D89985

P3181

Q29306674-76E4A29C-9205-482F-8B14-0755C651BD29

P356

Q29306674-B650AB92-7F5D-4C9E-B9CE-C18697308EDB

P433

Q29306674-70211EE3-F2F6-4CCE-9F51-FD11805FACAB

P478

Q29306674-5687708E-1F1A-48F8-8DE2-B134821736E2

P50

Q29306674-8815FBC7-5553-43ED-A525-C9B460237EC1

Q29306674-9B87DB5F-0EF4-4C3B-A088-9EFEBA77E782

Q29306674-B7995D5B-943E-4009-B849-9F2AA4086363

P577

Q29306674-5E5A07A6-91C0-4D19-87C3-02351A1A47D5

P698

Q29306674-E80B2E00-C1DF-4AB9-8E01-377940CB7A3D

P932

Q29306674-E12125BD-408D-46EB-BC1B-49BAA3E9320C

P3181

P356

CIRCRESAHA.110.230698

P1433

Circulation Research

P1476

cGMP signals modulate cAMP lev ...... signaling in cardiac myocytes

@en

P2093

Anna Terrin

http://www.w3.org/2001/XMLSchema#string

Anna Zoccarato

http://www.w3.org/2001/XMLSchema#string

Frank Gesellchen

http://www.w3.org/2001/XMLSchema#string

Godfrey Smith

http://www.w3.org/2001/XMLSchema#string

Laura Ashley Fields

http://www.w3.org/2001/XMLSchema#string

Marco Berrera

http://www.w3.org/2001/XMLSchema#string

Margaret Anne Craig

http://www.w3.org/2001/XMLSchema#string

Nicoletta Concetta Surdo

http://www.w3.org/2001/XMLSchema#string

P2860

Cardiomyocytes as effectors of nitric oxide signalling

Differential regulation of endothelial cell permeability by cGMP via phosphodiesterases 2 and 3

Cyclic nucleotide phosphodiesterase (PDE) superfamily: A new target for the development of specific therapeutic agents

Cyclic nucleotide phosphodiesterase activity, expression, and targeting in cells of the cardiovascular system

Molecular determinants for cyclic nucleotide binding to the regulatory domains of phosphodiesterase 2A

Interaction of the regulatory subunit (RII) of cAMP-dependent protein kinase with RII-anchoring proteins occurs through an amphipathic helix binding motif

Cyclic nucleotide phosphodiesterase-mediated integration of cGMP and cAMP signaling in cells of the cardiovascular system

Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling

Spatiotemporal dynamics of guanosine 3',5'-cyclic monophosphate revealed by a genetically encoded, fluorescent indicator

The effect of atrial natriuretic factor on force development in rat cardiac trabeculae.

P304

929-939

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3320992

http://www.w3.org/2001/XMLSchema#string

P356

10.1161/CIRCRESAHA.110.230698

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

108

http://www.w3.org/2001/XMLSchema#string

P50

Graham Hamilton

Manuela Zaccolo

Alessandra Stangherlin

P577

2011-02-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21330599

http://www.w3.org/2001/XMLSchema#string

P932

3083836

http://www.w3.org/2001/XMLSchema#string